Skip to content

The effect of an intraoperative, goal-directed volume protocol in abdominal surgery within an accelerated recovery program after surgery (Enhanced Recovery Program After Surgery: ERAS-Program)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN94786070
Enrollment
42
Registered
2008-03-27
Start date
2008-02-05
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic resection above the peritoneal reflection Digestive System Colonic resection above the peritoneal reflection

Interventions

Targeted-volume application guided by esophageal doppler vs conventional volume application

Sponsors

Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Written patient consent 2. Patients who undergo colonic resection above the peritoneal reflection 3. Patients who are treated within the context of an accelerated post-operative recovery program

Exclusion criteria

Exclusion criteria: 1. Accommodation in an institution due to an official or judicial order 2. No written consent from patient 3. Unwillingness to allow storage and sharing of anonymised disease data in the context of the clinical study 4. Simultaneous participation of the patient in another study or having been in a study which was terminated less than one week ago 5. American Society of Anaesthesiologists (ASA) classification >III 6. Advanced disease of the oesophagus of nasopharyngeal cavity 7. Operations in the area of the oesophagus or nasopharynx within the last 3 months 8. Systemic steroid therapy 9. Moderate or severe heart valve disease 10. von Willebrands disease 11. History of bleeding tendency 12. Liver disease (Child B or C cirrhosis, End-Stage Liver Disease [MELD] score >17) 13. Age 2.0 mg/dL) 15. Chronic heart failure New York Heart Association (NYHA) class III or IV 16. History of intracranial haemorrhage 17. Allergy to hydroxy-ethyl starch

Design outcomes

Primary

MeasureTime frame
Difference in the amount of intravenously administered crystalloid and colloid fluid on the day of operation

Secondary

MeasureTime frame
1. Reduction of the intraoperative requirement for vasoactive drugs 2. Time to hospital discharge 3. Rate of postoperative complications (pain, delirium. infections, cardiac, pulmonary, gastrointestinal and renal dysfunction). Patients will be monitored until they fulfill the hospital discharge criteria or up to 30th postoperative day.

Countries

Germany, Netherlands, Norway

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026